Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases

Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue

(2012) Sergio Sabbatani et al.   Brazilian Journal of Infectious Diseases

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy

(2011) H.L. Hébert et al.   BRITISH JOURNAL OF DERMATOLOGY

Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?

(2011) Pratima Sharma et al.   GASTROENTEROLOGY

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12

(2011) Stefano M. Santini et al.   PLoS One

Successful clearance of hepatitis C virus with pegylated interferon  -2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

(2010) I. Mederacke et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriasis Associated with Hepatitis C but Not with Hepatitis B

(2010) Arnon D. Cohen et al.   DERMATOLOGY

Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons

(2010) Josh Gregorio et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis

(2010) Robert Bissonnette et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection

(2009) S. E. Behnam et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab

(2009) Antonio Giovanni Richetta et al.   Dermatologic Therapy

Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-α and interferon-α

(2009) R. Bergman et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation

(2009) Amylynne J. Frankel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Antimicrobial peptides and self-DNA in autoimmune skin inflammation

(2008) Michel Gilliet et al.   CURRENT OPINION IN IMMUNOLOGY

Psoriasis-Exazerbation bei Therapie mit α-Interferon

(2008) F. Hartmann et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

(2008) Justin M. Ko et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Type I Interferon: Potential Therapeutic Target for Psoriasis?

(2008) Yihong Yao et al.   PLoS One